ASLAN Pharmaceuticals Limited Analysis
| Analyst Ratings |
|
Average Target Price
|
5.50
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.22
|
0.00
|
0.22
|
100.00%
|
|
2022-12-31
|
-0.23
|
0.00
|
0.23
|
100.00%
|
|
2022-09-30
|
-0.19
|
-0.16
|
0.03
|
15.79%
|
|
2022-06-30
|
-0.12
|
-0.19
|
-0.07
|
-58.33%
|
|
2022-03-31
|
-0.10
|
-0.19
|
-0.09
|
-90.00%
|
|
2021-12-31
|
-0.14
|
-0.16
|
-0.02
|
-14.29%
|
|
2021-09-30
|
-0.13
|
-0.12
|
0.01
|
7.69%
|
|
2021-06-30
|
-0.11
|
-0.07
|
0.04
|
36.36%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.54
|
|
2021-12-31
|
-0.50
|
|
2020-12-31
|
-0.45
|
|
2019-12-31
|
-1.43
|
|
2018-12-31
|
-1.38
|
|
2017-12-31
|
-0.99
|